semaglutide weight loss brain cells restores astrocyte–vascular interactions and blood–brain barrier integrity in a model of diet-induced metabolic syndrome | Diabetology & Metabolic Syndrome How Weight Loss Drugs May

As the new generation of GLP-1 medicines approaches, exciting new opportunities to assess the benefits and safety profile of new combinations diabetesjournals.org/care/article/4 Subcutaneous Amycretin moves the needle with up to 22% weight loss over 36 wks in P2 #obesity @novonordisk novonordisk.com/news-and-media

Arnett DK, et al

I did a ton of research and it led me to choose the best surgeon in town

Monitor Your Progress Keep track of your weight, dietary intake, and physical activity regularly

This lack of research raises concerns because non-diabetic patients face different risks and benefits than diabetic patients

That said, we are happy to collect your insurance information and provide a superbill for out-of-network reimbursement